Epizyme, Inc. (24)

Browse by Contract Category

Contracts

Fifth Amendment to Lease dated as of August 11, 2021, by and between the Company and ARE-TECH Square, LLC (Filed With SEC on August 16, 2021)
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan (Filed With SEC on May 6, 2021)
Amended and Restated Loan Agreement dated as of November 3, 2020 by and among the Registrant and BioPharma Credit Investments V (Master) LP, BPCR Limited Partnership and BioPharma... (Filed With SEC on February 23, 2021)
Amended and Restated Collaboration and License Agreement dated as of March 12, 2015, by and between the Registrant and Eisai Co. Ltd (Filed With SEC on February 23, 2021)
Description of Securities of the Registrant (Filed With SEC on February 27, 2020)
Form of Stock Option Agreement under 2013 Stock Incentive Plan (Filed With SEC on May 6, 2021)
Non-Employee Director Compensation Program, effective January 1, 2021 (Filed With SEC on February 23, 2021)
Employment Offer Letter between the Company and Victoria Vakiener, dated October 23, 2018 (Filed With SEC on February 23, 2021)
Amendment No. 2 to Collaboration Agreement dated September 17, 2020 by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on November 6, 2020)
Employment Offer Letter between the Company and Jeffery Kutok, dated February 21, 2020 (Filed With SEC on May 4, 2020)
Amendment to Collaboration Agreement dated March 10, 2020 by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on May 4, 2020)
First Amendment to 2013 Stock Incentive Plan (Filed With SEC on May 4, 2020)
Loan Agreement dated as of November 4, 2019 by and between the Registrant and BioPharma Credit Investments V (Master) LP and BioPharma Credit PLC (Filed With SEC on February 27, 2020)
Warrant Agreement dated as of November 4, 2019 by and between the Registrant and RPI Finance Trust (Filed With SEC on February 27, 2020)
Purchase Agreement dated as of November 4, 2019 by and between the Registrant and RPI Finance Trust (Filed With SEC on February 27, 2020)
Guaranty and Security Agreement dated as of November 18, 2019 by and between the Registrant and BioPharma Credit PLC (Filed With SEC on February 27, 2020)
Non-Employee Director Compensation Program (Filed With SEC on August 9, 2019)
Employment Offer Letter between the Company and Paolo Tombesi, dated July 1, 2019 (Filed With SEC on August 9, 2019)
Form of Series A Preferred Stock Certificate (Filed With SEC on March 7, 2019)
Underwriting Agreement related to the Preferred Offering, dated March 6, 2019, by and among the Company and Jefferies, LLC, Citigroup Global Markets, Inc. and Cowen and Company,... (Filed With SEC on March 7, 2019)
Underwriting Agreement related to the Common Offering, dated March 6, 2019, by and among the Company and Jefferies, LLC, Citigroup Global Markets, Inc. and Cowen and Company, as... (Filed With SEC on March 7, 2019)
Executive Severance and Change in Control Plan (Filed With SEC on February 26, 2019)
Non-Employee Director Compensation Program (Filed With SEC on February 26, 2019)
Form of Restricted Stock Unit Agreement under 2013 Stock Incentive Plan (Filed With SEC on February 26, 2019)